March 2008 Volume 41 Number 6, pp 505 - 596
---------------------------------------------------------------------
If you are unable to access the articles in this Table of
Contents e-alert, your library may not subscribe to
Bone Marrow Transplantation. Library recommendation through
our online recommendation form is a simple way to make
your librarian aware that this journal is valuable to your research.
Recommend now at
http://ealerts.nature.com/cgi-bin24/DM/y/ejtr0Xztnp0Hhn0BEyb0Et .
---------------------------------------------------------------------
A combined print and online personal subscription to this journal
gives you your own print copy and access to the entire website
including all back issues. Purchasing a subscription is easy; use
our online order form at
http://ealerts.nature.com/cgi-bin24/DM/y/ejtr0Xztnp0Hhn0BQAl0EL
to start your subscription today.
----------------------
REVIEW
----------------------
Autologous graft-versus-host disease: harnessing anti-tumor immunity
through impaired self-tolerance
J Kline, S Subbiah, H M Lazarus and K van Besien
Abstract: http://ealerts.nature.com/cgi-bin24/DM/y/ejtr0Xztnp0Hhn0Bq6J0E7
Article: http://ealerts.nature.com/cgi-bin24/DM/y/ejtr0Xztnp0Hhn0Bq6K0E8
Functional analysis of cytomegalovirus-specific T lymphocytes compared
to tetramer assay in patients undergoing hematopoietic stem cell
transplantation
Y Morita-Hoshi, Y Heike, M Kawakami, T Sugita, O Miura, S-W Kim, S-I
Mori, T Fukuda, R Tanosaki, K Tobinai and Y Takaue
Abstract: http://ealerts.nature.com/cgi-bin24/DM/y/ejtr0Xztnp0Hhn0Bq6L0EA
Article: http://ealerts.nature.com/cgi-bin24/DM/y/ejtr0Xztnp0Hhn0Bq6M0EB
Preinfusion variables predict the predominant unit in the setting of
reduced-intensity double cord blood transplantation
R L Haspel, G Kao, B Y Yeap, C Cutler, R J Soiffer, E P Alyea, V T Ho,
J Koreth, B R Dey, S L McAfee, E C Attar, T Spitzer, J H Antin and K K
Ballen
Abstract: http://ealerts.nature.com/cgi-bin24/DM/y/ejtr0Xztnp0Hhn0Bq6N0EC
Article: http://ealerts.nature.com/cgi-bin24/DM/y/ejtr0Xztnp0Hhn0Bq6O0ED
Combination of enzyme replacement and hematopoietic stem cell
transplantation as therapy for Hurler syndrome
J Tolar, S S Grewal, K J Bjoraker, C B Whitley, E G Shapiro, L Charnas
and P J Orchard
Abstract: http://ealerts.nature.com/cgi-bin24/DM/y/ejtr0Xztnp0Hhn0Bq6P0EE
Article: http://ealerts.nature.com/cgi-bin24/DM/y/ejtr0Xztnp0Hhn0Bq6Q0EF
Allogeneic hematopoietic cell transplantation for metastatic breast
cancer
N T Ueno, J D Rizzo, T Demirer, Y C Cheng, U Hegenbart, M-J Zhang, M
Bregni, A Carella, D Blaise, A Bashey, J D Bitran, B J Bolwell, G J
Elfenbein, K K Fields, C O Freytes, R P Gale, H M Lazarus, R E
Champlin, P J Stiff and D Niederwieser
Abstract: http://ealerts.nature.com/cgi-bin24/DM/y/ejtr0Xztnp0Hhn0Bq6R0EG
Article: http://ealerts.nature.com/cgi-bin24/DM/y/ejtr0Xztnp0Hhn0Bq6S0EH
High-dose melphalan and autologous stem cell transplantation as
consolidation treatment in patients with chemosensitive ovarian
cancer: results of a single-institution randomized trial
C Papadimitriou, U Dafni, A Anagnostopoulos, G Vlachos, Z Voulgaris, A
Rodolakis, G Aravantinos, A Bamias, G Bozas, E Kiosses, G M
Gourgoulis, E Efstathiou and M A Dimopoulos
Abstract: http://ealerts.nature.com/cgi-bin24/DM/y/ejtr0Xztnp0Hhn0Bq6T0EI
Article: http://ealerts.nature.com/cgi-bin24/DM/y/ejtr0Xztnp0Hhn0Bq6U0EJ
Pegase 03: a prospective randomized phase III trial of FEC with or
without high-dose thiotepa, cyclophosphamide and autologous stem cell
transplantation in first-line treatment of metastatic breast cancer
P Biron, M Durand, H Roche, T Delozier, C Battista, P Fargeot, D
Spaeth, T Bachelot, E Poiget, F Monnot, M L Tanguy and H Cure
Abstract: http://ealerts.nature.com/cgi-bin24/DM/y/ejtr0Xztnp0Hhn0Bq6V0EK
Article: http://ealerts.nature.com/cgi-bin24/DM/y/ejtr0Xztnp0Hhn0Bq6W0EL
Stem cell-derived cardiomyocytes after bone marrow and heart
transplantation
R A de Weger, I Verbrugge, A H Bruggink, M M van Oosterhout, Y de
Souza, D F van Wichen, F H J Gmelig-Meyling, N de Jonge and L F
Verdonck
Abstract: http://ealerts.nature.com/cgi-bin24/DM/y/ejtr0Xztnp0Hhn0Bq6X0EM
Article: http://ealerts.nature.com/cgi-bin24/DM/y/ejtr0Xztnp0Hhn0Bq6Y0EN
Low-dose MTX for the treatment of acute and chronic graft-versus-host
disease in children
J Inagaki, Y Nagatoshi, M Hatano, N Isomura, M Sakiyama and J Okamura
Abstract: http://ealerts.nature.com/cgi-bin24/DM/y/ejtr0Xztnp0Hhn0Bq6Z0EO
Article: http://ealerts.nature.com/cgi-bin24/DM/y/ejtr0Xztnp0Hhn0Bq6a0EV
In vitro and in vivo evaluation of the haematopoietic potential of
skeletal muscle in a non-human primate model
C Haond, M Drouet, S Derdouch, M-L Bonnet, F Norol, J-F Mayol, W
Vainchenker, R LeGrand, A G Turhan and F Herodin
Abstract: http://ealerts.nature.com/cgi-bin24/DM/y/ejtr0Xztnp0Hhn0Bq6b0EW
Article: http://ealerts.nature.com/cgi-bin24/DM/y/ejtr0Xztnp0Hhn0Bq6c0EX
----------------------
LETTERS TO THE EDITOR
----------------------
Heparin toxicity following allogeneic bone marrow infusion
M J Williamson, G C Kudva and S M Pincus
http://ealerts.nature.com/cgi-bin24/DM/y/ejtr0Xztnp0Hhn0Bq6d0EY
Chimerism does not predict for outcome after alemtuzumab-based
conditioning: lineage-specific analysis of chimerism of specific
diseases may be more informative
Z Y Lim, L Pearce, W Ingram, A Y L Ho, G J Mufti and A Pagliuca
http://ealerts.nature.com/cgi-bin24/DM/y/ejtr0Xztnp0Hhn0Bq6e0EZ
Comparison of peripheral blood and bone marrow samples for detection
of post transplant mixed chimerism
J Stumph, C L Vnencak-Jones, T Koyama and H Frangoul
http://ealerts.nature.com/cgi-bin24/DM/y/ejtr0Xztnp0Hhn0Bq6f0Ea
Durable remission of large B-cell lymphoma transformed from
lymphoplasmacytic lymphoma/Waldenstrom macroglobulinemia successfully
treated with sequential immunochemotherapy followed by
reduced-intensity allogeneic stem cell transplantation
R Yamamoto, A Takaori-Kondo, J Kanda, K Imada, T Ichinohe, T Ishikawa,
K Ohmori and T Uchiyama
http://ealerts.nature.com/cgi-bin24/DM/y/ejtr0Xztnp0Hhn0Bq6g0Eb
Successful therapy of chronic graft-versus-host disease manifesting as
pure red cell aplasia with single-agent rituximab
D M Benson, M K Smith, D Krugh and S M Devine
http://ealerts.nature.com/cgi-bin24/DM/y/ejtr0Xztnp0Hhn0Bq6h0Ec
---------------------------------------------------------------------
Submit your research through our online submission site at
http://ealerts.nature.com/cgi-bin24/DM/y/ejtr0Xztnp0Hhn0geg0E7 . Papers benefit
from wide readership through hosting on nature.com and inclusion in
the leading abstracting and indexing services. Rapid publication is
also assured through Advance Online Publication.
======================================================================
You have been sent this Table of Contents Alert because you have opted in to receive it.
You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at:
http://www.nature.com/myaccount
(You will need to log in to be recognised as a nature.com registrant).
For further technical assistance, please contact our registration department:
registration@nature.com
For print subscription enquiries, please contact our subscription department:
subscriptions@nature.com
For other enquiries, please contact customer feedback department:
feedback@nature.com
Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA
Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne -
San Diego - San Francisco - Washington - New York - Boston
Macmillan Publishers Limited is a company incorporated in England and
Wales under company number 785998 and whose registered office is located
at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS.
(c) Copyright 2008 Nature Publishing Group
======================================================================
